- Location
Hospira
"-
89% of Customers Believe Strategic Partnership to Be The Most Important Attribute
Nov 26, 2014Over half (53%) of life sciences and healthcare manufacturers prioritise quality assurance over cost in selecting their supply chain partner, and the industry is on the fence (48% vs. 52%) about whether the pharmaceutical industry will soon ...
Tags: Healthcare, Service
-
Hospira Struggles with Serious Problems Related to Its Gemstar Infusion System
Nov 7, 2014Hospira continues to struggle with serious problems related to its GemStar Infusion System and its accessories. The latest bad news came Wednesday, when the FDA designated a recall of the GemStar Power Supply, 3VDC, as Class I. The ...
-
Medtronic Isn't The Only Medtech Company Facing Criticism
Aug 18, 2014Medtronic isn’t the only medtech company facing criticism over potentially moving its headquarters overseas. Hospira is also taking flak—even though it is only rumored so far to be in talks with French company Danone for a ...
-
The Lake Forest Has Spent More Than $1 Billion Across Its Global Operations.
Mar 14, 2014Just when Hospira Inc.'s Rocky Mount, NC–manufacturing facility was starting to think it could breathe a little easier, FDA delivered another Warning Letter. The Lake Forest, IL-–based manufacturer of pharmaceuticals, other ...
Tags: medical device, Health, Medicine
-
Monoclonal Antibody Agents Have Been Successfully Used in The Treatment of Tumors
Dec 23, 2013Currently, monoclonal antibody agents have been successfully used in the treatment of tumors, cancers and other serious diseases as a heavyweight in the biopharmaceutical industry. In 2009-2012, the market size of monoclonal antibody agents ...
-
FDA Has Classified a Hospira Recall of Its GemStar Infusion System as Class I
Dec 3, 2013First it was leaky battery damage. Now it is pressure sensor calibration drift. For the second time this year, the FDA has classified a Hospira recall of its GemStar Infusion System as Class I, which means there is potential for ...
-
Hospira Has Announced The Launch of The Sapphire Infusion System in The US
Oct 25, 2013Hospira, a provider of injectable drugs and infusion technologies, has announced the launch of the Sapphire infusion system in the US following regulatory approval from the US Food and Drug Administration (FDA). The Sapphire features an ...
Tags: ambulatory pumps, Hospira
-
Apotex Recalled of 21 Lots of Piperacillin and Tazobactam for Injection
May 15, 2013Apotex, on behalf of Hospira, has initiated a US-wide voluntary recall of 21 lots of Piperacillin and Tazobactam for Injection, USP 40.5 grams, over concerns that the recalled lots may show precipitation or crystallization in IV bag or IV ...
Tags: Apotex, Piperacillin
-
Apotex Has Issued a Voluntary Recall of 15 Lots of Piperacillin and Tazobactam
May 3, 2013Canada-based pharmaceutical company Apotex, on behalf of the manufacturer Hospira, has issued a voluntary recall of 15 lots of Piperacillin and Tazobactam for Injection, USP 40.5 grams, in the US. The affected lots of Piperacillin and ...
Tags: Apotex, Piperacillin, Tazobactam
-
FDA Has Granted 6 Months Pediatric Exclusivity for Hospira's Precedex Injection in The US
Mar 20, 2013The US Food and Drug Administration (FDA) has granted six months pediatric exclusivity for Hospira's Precedex (dexmedetomidine HCl) injection in the US. Precedex, an alpha-2 agonist, is approved for use only in adults and the US regulator ...
Tags: Hospira Precedex injection, Drug, FDA
-
Synta Pharmaceuticals Has Named Dr Sumant Ramachandra as The New President of R&D
Mar 19, 2013Synta Pharmaceuticals, a US-based biopharmaceutical company, has named Dr Sumant Ramachandra as the new president of research and development (R&D). Dr Ramachandra served as senior vice president, R&D, regulatory and medical affairs, and ...
Tags: Synta Pharma, biopharmaceutical company, biopharmaceutical
-
Hospira Is Voluntarily Recalling Multiple Lots of Five Different Injections
Feb 28, 2013Hospira is voluntarily recalling multiple lots of five different injections, due to reports of faulty packaging and contamination. According to the firm, the recall was took place as the consumers have reported that one lot of ...
Tags: Hospira, Injections, Medicine
-
FDA Has Approved Clinigen Healthcare's Supplemental New Drug Application for Foscavir
Jan 1, 2013The FDA has approved Clinigen Healthcare's supplemental new drug application (sNDA) for Foscavir (foscarnet sodium), a treatment for HIV/AIDS-related cytomegalovirus (CMV) infections and herpes. Hospira will distribute Foscavir to US ...
-
Hospira(HSP) Has Revamped Its Theradoc Clinical Surveillance System
Dec 19, 2012Hospira (HSP), a provider of injectable drugs and infusion technologies, has revamped its TheraDoc clinical surveillance system, which is designed to support hospital antimicrobial stewardship efforts. The new TheraDoc system version ...
Tags: medical technology, clinical surveillance system, medical equipement
-
Hospira Has Announced Hydromorphone Injection at User Level
Nov 29, 2012Hospira has announced a nationwide voluntary recall of one lot of Hydromorphone Injection, USP, 2mg/mL (C-II), 1mL fill in 2.5mL Carpuject, NDC 0409-1312-30 , due to a reported complaint of a single Carpuject containing more than the 1mL ...
Related Products
-
Veterinary Perfusion Pump Volumetric Infusion Pump Electric Pump Pet Dog Infusion Pump Animail Syringe Pump IV Sets Infusion Set Veterinary Infusion Pump
-
Medical Equipment Portable Medical Instrument Infusion Pump
-
Yssy-710 Medical Equipment Infusion Pump Syringe Pump Cost
-
Yssy-820 Hospital Operation Room ICU Portable Infusion Pump
-
Yssy-820dmedical Portable Volumetric IV Infusion Pump with Drug Library
-
Mindray Ipmtn Series IBP Cable to Abbott Connector Im2201 12 Pin IBP Cable for Hospira Pn 001c-30-70759
